SINGAPORE – China, India, Japan and Korea are prominent Asian players in the global biotech space, while Singapore has emerged as an increasingly notable global contributor, but there remains a gap in terms of contributions from other parts of Southeast Asia. A common theme emerging this week at the Phar-East Pharma and Biotech Festival (formerly known as the BioPharma Asia Convention) focused on ways to foster biotech and bioentrepreneurship in the region.